19:50 EDT Mersana Therapeutics (MRSN) trading halted, news pending
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRSN:
- Mersana Therapeutics Announces Reverse Stock Split
- Mersana Therapeutics announces 1-for-25 reverse stock split
- Mersana Therapeutics’ XMT-1660 Study: A Potential Game-Changer in Cancer Treatment
- Mersana Therapeutics Advances HER2-Targeted Cancer Therapy with XMT-2056 Study
- Mersana Therapeutics Settles Debt with Oxford Finance